Stefan K Barta

Summary

Affiliation: Montefiore Medical Center
Country: USA

Publications

  1. doi request reprint Synergy of sequential administration of a deglycosylated ricin A chain-containing combined anti-CD19 and anti-CD22 immunotoxin (Combotox) and cytarabine in a murine model of advanced acute lymphoblastic leukemia
    Stefan K Barta
    Albert Einstein College of Medicine, Montefiore Medical Center Moses Division, Bronx, NY 10467, USA
    Leuk Lymphoma 53:1999-2003. 2012
  2. pmc Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma
    Stefan K Barta
    Albert Einstein College of Medicine, Department of Oncology, Montefiore Medical Center, Bronx, New York, USA
    Cancer 118:3977-83. 2012

Detail Information

Publications2

  1. doi request reprint Synergy of sequential administration of a deglycosylated ricin A chain-containing combined anti-CD19 and anti-CD22 immunotoxin (Combotox) and cytarabine in a murine model of advanced acute lymphoblastic leukemia
    Stefan K Barta
    Albert Einstein College of Medicine, Montefiore Medical Center Moses Division, Bronx, NY 10467, USA
    Leuk Lymphoma 53:1999-2003. 2012
    ..These findings have led to a phase I clinical trial exploring this combination in adults with relapsed or refractory B-lineage ALL (ClinicalTrials.gov identifier NCT01408160)...
  2. pmc Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma
    Stefan K Barta
    Albert Einstein College of Medicine, Department of Oncology, Montefiore Medical Center, Bronx, New York, USA
    Cancer 118:3977-83. 2012
    ..The objective of the current analysis was to assess whether patient selection or other factors contributed to this improvement and to identify patients who are at the greatest risk for lethal toxicity...